farmaecFARMAKOEKONOMIKA. Modern Pharmacoeconomics and PharmacoepidemiologyФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология2070-49092070-4933IRBIS LLC10.17749/2070-4909/farmakoekonomika.2021.063farmaec-526Research ArticleREVIEW ARTICLESОБЗОРНЫЕ ПУБЛИКАЦИИArtificial intelligence in healthcare: possibilities of patent protectionИскусственный интеллект в здравоохранении. Возможности патентной охраны таких разработокЭриванцеваТ. Н.ErivantsevaT. N.

Эриванцева Татьяна Николаевна – заместитель директора. РИНЦ SPIN-код: 5161-0391

Бережковская наб., д. 30, корп. 1, Москва 121059, Россия

Erivantseva Tatyana Nikolaevna – Deputy Director. РИНЦ SPIN-код: 5161-0391

30 corp. 1 Berezhkovskaya Naberezhnaya, Moscow 121059, Russia

БлохинаЮ. В.BlokhinaYu. V.

Блохина Юлия Валерьевна – заведующая отделом медицины и медицинской техники

Бережковская наб., д. 30, корп. 1, Москва 121059, Россия

Blokhina Yulia Valeryevna – Head of Department of Medicine and Medical Technology

30 corp. 1 Berezhkovskaya Naberezhnaya, Moscow 121059, Russia

yblokhina@rupto.ruФедеральное государственное бюжетное учреждение «Федеральный институт промышленной собственности»РоссияFederal Institute of Industrial PropertyRussian Federation202126072021142270–276Copyright © Erivantseva T.N., Blokhina Y.V., 20212021Эриванцева Т.Н., Блохина Ю.В.Erivantseva T.N., Blokhina Y.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pharmacoeconomics.ru/jour/article/view/526

The article provides an overview of the advantages and issues associated with the use of artificial intelligence (AI) and machine learning (ML) in medicine. Based on the analysis of scientific publications, the leading healthcare areas using AI and ML have been identified. The applied problems that modern technologies allow to solve are described, as well as the goals that can be achieved using such technologies. The legal protection issues of technologies using AI are highlighted. A comparison is given of the key aspects of copyright and patent law, and the advantages of patent law and comprehensive patent protection of technologies for process automation in healthcare are presented. The possibilities of complex patent protection and its strategy in the leading areas of AI use in healthcare are considered on specific examples.

В статье представлен обзор преимуществ и проблем, связанных с использованием искусственного интеллекта (ИИ) и машинного обучения (МО) в медицине. На основании анализа научных публикаций определены лидирующие направления в сфере здравоохранения, использующие ИИ и МО. Описаны прикладные задачи, которые позволяют решить современные технологии, а также цели, которые могут быть достигнуты при использовании таких технологий. Освещены вопросы правовой охраны технологий с применением ИИ. Дано сравнение ключевых аспектов авторского и патентного права, а также представлены преимущества патентного права и комплексной патентной охраны технологий автоматизации процессов в области здравоохранения. На конкретных примерах рассмотрены возможности комплексной патентной охраны и ее стратегия в лидирующих направлениях использования ИИ в области здравоохранения.

Искусственный интеллектсистема поддержки клинических решенийрезультаты интеллектуальной деятельностиавторское правопатентное правоизобретениепромышленный образецпрограмма ЭВМArtificial intelligenceclinical decision support systemthe results of intellectual activitycopyrightpatent lawinventionindustrial modelcomputer programReferencesSchork N.J. Artificial intelligence and personalized medicine. Cancer Treat Res. 2019; 178: 265–83. https://doi.org/10.1007/978-3-030-16391-4_11.Schork N.J. Artificial intelligence and personalized medicine. Cancer Treat Res. 2019; 178: 265–83. https://doi.org/10.1007/978-3-030-16391-4_11.Davenport T., Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019; 6 (2): 94–8. https://doi.org/10.7861/futurehosp.6-2-94.Davenport T., Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019; 6 (2): 94–8. https://doi.org/10.7861/futurehosp.6-2-94.Uddin M., Wang Y., Woodbury-Smith M. Artificial intelligence for precision medicine in neurodevelopmental disorders. NPJ Digit. Med. 2019; 2: 112. https://doi.org/10.1038/s41746-019-0191-0.Uddin M., Wang Y., Woodbury-Smith M. Artificial intelligence for precision medicine in neurodevelopmental disorders. NPJ Digit. Med. 2019; 2: 112. https://doi.org/10.1038/s41746-019-0191-0.Mehta N., Pandit A., Shukla S. Transforming healthcare with big data analytics and artificial intelligence: a systematic mapping study. J Biomed Inform. 2019; 100: 103311. https://doi.org/10.1016/j.jbi.2019.103311.Mehta N., Pandit A., Shukla S. Transforming healthcare with big data analytics and artificial intelligence: a systematic mapping study. J Biomed Inform. 2019; 100: 103311. https://doi.org/10.1016/j.jbi.2019.103311.El Naqa I., Kosorok M.R., Jin J., Mierzwa M., Ten Haken R.K. Prospects and challenges for clinical decision support in the era of big data. JCO Clin Cancer Inform. 2018; 2: CCI.18.00002. https://doi.org/10.1200/cci.18.00002.El Naqa I., Kosorok M.R., Jin J., Mierzwa M., Ten Haken R.K. Prospects and challenges for clinical decision support in the era of big data. JCO Clin Cancer Inform. 2018; 2: CCI.18.00002. https://doi.org/10.1200/cci.18.00002.Xu J., Yang P., Xue S., et al. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Hum Genet. 2019; 138 (2): 109–24. https://doi.org/10.1007/s00439-019-01970-5.Xu J., Yang P., Xue S., et al. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Hum Genet. 2019; 138 (2): 109–24. https://doi.org/10.1007/s00439-019-01970-5.Kermany D.S., Goldbaum M., Cai W., et al. Identifying medical diagnoses and treatable diseases by image-based deep learning. Cell. 2018; 172 (5): 1122–31e.9. https://doi.org/10.1016/j.cell.2018.02.010.Kermany D.S., Goldbaum M., Cai W., et al. Identifying medical diagnoses and treatable diseases by image-based deep learning. Cell. 2018; 172 (5): 1122–31e.9. https://doi.org/10.1016/j.cell.2018.02.010.Esteva A., Kuprel B., Novoa R., et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017; 542 (7639): 115–8. https://doi.org/10.1038/nature21056.Esteva A., Kuprel B., Novoa R., et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017; 542 (7639): 115–8. https://doi.org/10.1038/nature21056.Poplin R., Varadarajan A.V., Blumer K., et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng. 2018; 2: 158–64. https://doi.org/10.1038/s41551-018-0195-0.Poplin R., Varadarajan A.V., Blumer K., et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng. 2018; 2: 158–64. https://doi.org/10.1038/s41551-018-0195-0.Kantarjian H., Yu P.P. Artificial intelligence, big data, and cancer. JAMA Oncology. 2015; 1 (5): 573. https://doi.org/10.1001/jamaoncol.2015.1203.Kantarjian H., Yu P.P. Artificial intelligence, big data, and cancer. JAMA Oncology. 2015; 1 (5): 573. https://doi.org/10.1001/jamaoncol.2015.1203.Shimizu H., Nakayama K.I. Artificial intelligence in oncology. Cancer Sci. 2020; 111 (5): 1452–60. https://doi.org/10.1111/cas.14377.Shimizu H., Nakayama K.I. Artificial intelligence in oncology. Cancer Sci. 2020; 111 (5): 1452–60. https://doi.org/10.1111/cas.14377.Ehteshami Bejnordi B., Veta M., Johannes van Diest P., et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017; 318: 2199–2210. https://doi.org/10.1001/jama.2017.14585.Ehteshami Bejnordi B., Veta M., Johannes van Diest P., et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017; 318: 2199–2210. https://doi.org/10.1001/jama.2017.14585.Ainscough B.J., Barnell E.K., Ronning P., et al. A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. Nat Genet. 2018; 50 (12): 1735–43. https://doi.org/10.1038/s41588-018-0257-y.Ainscough B.J., Barnell E.K., Ronning P., et al. A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. Nat Genet. 2018; 50 (12): 1735–43. https://doi.org/10.1038/s41588-018-0257-y.Chang P., Grinband J., Weinberg B.D., et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. AJNR Am J Neuroradiol. 2018; 39 (7): 1201–7. https://doi.org/10.3174/ajnr.A5667.Chang P., Grinband J., Weinberg B.D., et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. AJNR Am J Neuroradiol. 2018; 39 (7): 1201–7. https://doi.org/10.3174/ajnr.A5667.Liang G., Fan W., Luo H., et al. The emerging roles of artificial intelligence in cancer drug development and precision therapy. Biomed Pharmacother. 2020; 128: 110255. https://doi.org/10.1016/j.biopha.2020.110255.Liang G., Fan W., Luo H., et al. The emerging roles of artificial intelligence in cancer drug development and precision therapy. Biomed Pharmacother. 2020; 128: 110255. https://doi.org/10.1016/j.biopha.2020.110255.Siegersma K.R., Leiner T., Chew D.P., et al. Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist. Neth Heart J. 2019; 27 (9): 403–13. https://doi.org/10.1007/s12471-019-01311-1.Siegersma K.R., Leiner T., Chew D.P., et al. Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist. Neth Heart J. 2019; 27 (9): 403–13. https://doi.org/10.1007/s12471-019-01311-1.Tai A.M., Albuquerque A., Carmona N.E., et al. Machine learning and big data: implications for disease modeling and therapeutic discovery in psychiatry. Artif Intell Med. 2019; 99: 101704. https://doi.org/10.1016/j.artmed.2019.101704.Tai A.M., Albuquerque A., Carmona N.E., et al. Machine learning and big data: implications for disease modeling and therapeutic discovery in psychiatry. Artif Intell Med. 2019; 99: 101704. https://doi.org/10.1016/j.artmed.2019.101704.Brasil S., Pascoal C., Francisco R., et al. Artificial intelligence (AI) in rare diseases: is the future brighter? Genes (Basel). 2019; 10 (12): 978. https://doi.org/10.3390/genes10120978.Brasil S., Pascoal C., Francisco R., et al. Artificial intelligence (AI) in rare diseases: is the future brighter? Genes (Basel). 2019; 10 (12): 978. https://doi.org/10.3390/genes10120978.Kindle R.D., Badawi O., Celi L.A., Sturland S. Intensive care unit telemedicine in the era of big data, artificial intelligence, and computer clinical decision support systems. Critical Care Clinics. 2019; 35 (3): 483–95. https://doi.org/10.1016/j.ccc.2019.02.005.Kindle R.D., Badawi O., Celi L.A., Sturland S. Intensive care unit telemedicine in the era of big data, artificial intelligence, and computer clinical decision support systems. Critical Care Clinics. 2019; 35 (3): 483–95. https://doi.org/10.1016/j.ccc.2019.02.005.Cosgriff C.V., Celi L.A., Stone D.J. Critical care, critical data. Biomed Eng Comput Biol. 2019; 10: 1179597219856564. https://doi.org/10.1177/1179597219856564.Cosgriff C.V., Celi L.A., Stone D.J. Critical care, critical data. Biomed Eng Comput Biol. 2019; 10: 1179597219856564. https://doi.org/10.1177/1179597219856564.Wang M., Xia C., Huang L., et al. Deep learning-based triage and analysis of lesion burden for COVID-19: a retrospective study with external validation. Lancet Digit Health. 2020; 2 (10): e506–15. https://doi.org/10.1016/S2589-7500(20)30199-0.Wang M., Xia C., Huang L., et al. Deep learning-based triage and analysis of lesion burden for COVID-19: a retrospective study with external validation. Lancet Digit Health. 2020; 2 (10): e506–15. https://doi.org/10.1016/S2589-7500(20)30199-0.Vardhanabhuti V. CT scan AI-aided triage for patients with COVID-19 in China. Lancet Digit Health. 2020; 2 (10): e494–5. https://doi.org/10.1016/S2589-7500(20)30222-3.Vardhanabhuti V. CT scan AI-aided triage for patients with COVID-19 in China. Lancet Digit Health. 2020; 2 (10): e494–5. https://doi.org/10.1016/S2589-7500(20)30222-3.Liang W., Yao J., Chen A., et al. Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020; 11: 3543. https://doi.org/10.1038/s41467-020-17280-8.Liang W., Yao J., Chen A., et al. Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020; 11: 3543. https://doi.org/10.1038/s41467-020-17280-8.Fernandes M., Vieira S.M., Leite F., et al. Clinical decision support systems for triage in the emergency department using intelligent systems: a review. Artif Intell Med. 2020; 102: 101762. https://doi.org/10.1016/j.artmed.2019.101762.Fernandes M., Vieira S.M., Leite F., et al. Clinical decision support systems for triage in the emergency department using intelligent systems: a review. Artif Intell Med. 2020; 102: 101762. https://doi.org/10.1016/j.artmed.2019.101762.Kim H.S., Kim D.J., Yoon K.H. Medical big data is not yet available: why we need realism rather than exaggeration. Endocrinol Metab (Seoul). 2019; 34 (4): 349–54. https://doi.org/10.3803/EnM.2019.34.4.349.Kim H.S., Kim D.J., Yoon K.H. Medical big data is not yet available: why we need realism rather than exaggeration. Endocrinol Metab (Seoul). 2019; 34 (4): 349–54. https://doi.org/10.3803/EnM.2019.34.4.349.Manrique de Lara A., Peláez-Ballestas I. Big data and data processing in rheumatology: bioethical perspectives. Clin Rheumatol. 2020; 39: 1007–14. https://doi.org/10.1007/s10067-020-04969-w.Manrique de Lara A., Peláez-Ballestas I. Big data and data processing in rheumatology: bioethical perspectives. Clin Rheumatol. 2020; 39: 1007–14. https://doi.org/10.1007/s10067-020-04969-w.Sloane E.B., Silva J.R. Artificial intelligence in medical devices and clinical decision support systems. In: Clinical engineering handbook. 2nd ed. Elsevier; 2020: 556–68. https://doi.org/10.1016/B978-0-12-813467-2.00084-5.Sloane E.B., Silva J.R. Artificial intelligence in medical devices and clinical decision support systems. In: Clinical engineering handbook. 2nd ed. Elsevier; 2020: 556–68. https://doi.org/10.1016/B978-0-12-813467-2.00084-5.

The authors declare that there are no conflicts of interest present.